Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, Scotland.
Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot Watt University, Edinburgh, Scotland.
Mol Cancer Res. 2021 Feb;19(2):274-287. doi: 10.1158/1541-7786.MCR-20-0336. Epub 2020 Oct 23.
Elevated NF-κB activity is a contributory factor in many hematologic and solid malignancies. Nucleolar sequestration of NF-κB/RelA represses this elevated activity and mediates apoptosis of cancer cells. Here, we set out to understand the mechanisms that control the nuclear/nucleolar distribution of RelA and other regulatory proteins, so that agents can be developed that specifically target these proteins to the organelle. We demonstrate that RelA accumulates in intranucleolar aggresomes in response to specific stresses. We also demonstrate that the autophagy receptor, SQSTM1/p62, accumulates alongside RelA in these nucleolar aggresomes. This accumulation is not a consequence of inhibited autophagy. Indeed, our data suggest nucleolar and autophagosomal accumulation of p62 are in active competition. We identify a conserved motif at the N-terminus of p62 that is essential for nucleoplasmic-to-nucleolar transport of the protein. Furthermore, using a dominant-negative mutant deleted for this nucleolar localization signal (NoLS), we demonstrate a role for p62 in trafficking RelA and other aggresome-related proteins to nucleoli, to induce apoptosis. Together, these data identify a novel role for p62 in trafficking nuclear proteins to nucleolar aggresomes under conditions of cell stress, thus maintaining cellular homeostasis. They also provide invaluable information on the mechanisms that regulate the nuclear/nucleolar distribution of RelA that could be exploited for therapeutic purpose. IMPLICATIONS: The data open up avenues for the development of a unique class of therapeutic agents that act by targeting RelA and other aberrantly active proteins to nucleoli, thus killing cancer cells.
NF-κB 活性升高是许多血液系统恶性肿瘤和实体瘤的致病因素。核仁隔离 NF-κB/RelA 可抑制这种活性升高并介导癌细胞凋亡。在这里,我们着手了解控制 RelA 和其他调节蛋白核/核仁分布的机制,以便开发专门将这些蛋白靶向细胞器的药物。我们证明,RelA 会在响应特定应激时积聚在核仁内的聚集物中。我们还证明,自噬受体 SQSTM1/p62 与 RelA 一起在这些核仁聚集物中积聚。这种积累不是自噬受抑制的结果。事实上,我们的数据表明 p62 在核仁内和自噬体中的积累是积极竞争的。我们确定了 p62 的 N 端保守基序,该基序对于蛋白质从核质到核仁的转运是必需的。此外,我们使用缺失该核仁定位信号(NoLS)的显性负突变体,证明了 p62 在将 RelA 和其他聚集体相关蛋白运输到核仁以诱导细胞凋亡中的作用。这些数据共同确定了 p62 在细胞应激条件下将核蛋白运输到核仁聚集物中的新作用,从而维持细胞内稳态。它们还提供了有关调节 RelA 核/核仁分布的机制的宝贵信息,这些信息可用于治疗目的。意义:这些数据为开发一类独特的治疗药物开辟了途径,这些药物通过将 RelA 和其他异常活跃的蛋白靶向核仁来发挥作用,从而杀死癌细胞。